Esther A. Odekunle is a distinguished British neurobiologist and antibody engineer whose career is marked by significant contributions to the fields of neurobiology and therapeutic development. After earning her B.S. in biochemistry and Ph.D. in neurobiology from Queen Mary University of London, where she focused on the neuropeptide systems in starfish, Odekunle demonstrated a commitment to exploring complex biological systems. Her choice to study starfish, known for their remarkable regenerative abilities, reflects her innovative approach to research.

Transitioning into the pharmaceutical industry, Odekunle has excelled as an antibody engineer, where she specializes in cloning antibodies from B cells to develop targeted treatments for diseases such as cancers and viral infections. Her work is pivotal in advancing therapeutic options, showcasing her ability to bridge the gap between scientific research and practical medical applications. Odekunle’s dedication to her field is evident in her efforts to navigate the complexities of industry regulations while maintaining a strong voice in the scientific community.

In addition to her research, Odekunle is a passionate advocate for diversity in STEM. She actively promotes the visibility of underrepresented professionals through various platforms, including her YouTube channel, where she shares educational content and discusses critical issues such as systemic racism in science. Her commitment to mentorship and encouragement of aspiring scientists from diverse backgrounds highlights her role as a leader in fostering inclusivity.

Recognized for her achievements, Odekunle was named a Rising Star Finalist in the Black British Business Awards’ STEM category in 2021. Her ongoing contributions to science and advocacy for diversity continue to inspire the next generation of scientists, making her a prominent figure in both academia and the pharmaceutical industry.